Proven leaders in developing rare disease treatments

Executive Team

“The team at Marathon Pharmaceuticals was the first to focus on this complex, little known group of diseases—educating physicians and patients about the diagnosis, supporting clinical trials and making new drugs available. In the large world of pharmaceuticals, we are a small group of patients, but we mattered to the people at Marathon.”

— Desiree Lyon, Executive Director, American Porphyria Foundation